A survey of ex vivo/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype
Brian L. Ellis(The University of Texas Southwestern Medical Center), Matthew H. Porteus(Lucile Packard Children's Hospital), Jenny C. Barker(The University of Texas Southwestern Medical Center), Jon P. Connelly(St. Jude Children's Research Hospital), Robert J. Steininger(Center for Systems Biology), Matthew L. Hirsch(University of North Carolina at Chapel Hill)
Cited by 254
Related Papers
Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene Modification
|Molecular Cell|2008|709
A Survey of Validation Strategies for CRISPR-Cas9 Editing
|Scientific Reports|2018|365
ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection
|Science Immunology|2022|338